Menu
← Oncology Approval Tracker
FDA DECISION ·
Sunitinib (generic Sutent)
sunitinib malate · Sun Pharmaceutical Industries
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
First generic Sutent capsules for adults with advanced renal cell carcinoma, adjuvant use after nephrectomy for renal cell carcinoma at high risk of recurrence, GIST after imatinib progression or intolerance, or progressive well-differentiated pancreatic neuroendocrine tumors that are unresectable locally advanced or metastatic.
LAMPGEN ANALYSIS
Why it matters
The generic approval covers distinct disease and treatment settings for the same kinase inhibitor.
What research teams should watch
Document the relevant indication and reconcile capsule strength and dosing schedule for each setting.
PRIMARY RECORDS